Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE) that occurs in about half of patients. LN is characterized by glomerular deposition of immune complexes, leading to subendothelial, mesangial and subepithelial electron dense deposits, triggering immune cell infiltration and glomerular as well as tubulointerstitial injury. Monocytes and macrophages are abundantly present in inflammatory lesions, both in glomeruli and the tubulointerstitium. Here we discuss how monocytes and macrophages are involved in this process and how monocytes and macrophages may represent specific therapeutic targets to control LN.
Original languageEnglish
Article number103211
JournalAutoimmunity Reviews
Issue number12
Publication statusPublished - 1 Dec 2022


  • Kidney
  • Lupus
  • Macrophage
  • Nephritis
  • Treatment

Cite this